These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 191960)

  • 21. Characterization of the protective effect of radioprotective substances by means of long-term changes in oxygen consumption.
    Misustová J; Hosek B; Kautská J
    Strahlentherapie; 1980 Nov; 156(11):790-4. PubMed ID: 6933726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxicity of radioprotective agents to yeast.
    Markoe AM; Tannard JN
    Radiat Res; 1969 Jul; 39(1):90-100. PubMed ID: 5789050
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cellular mechanism of the radioprotective effect of mexamine on the colony-forming elements of bone marrow].
    Bogatyrev AV; Nikanorova NG; Timoshenko SI; Sverdlov AG
    Radiobiologiia; 1974; 14(2):290-2. PubMed ID: 4832889
    [No Abstract]   [Full Text] [Related]  

  • 24. [The action of anti-radiation sickness agents upon the pain sensitivity of animals].
    Strelkov RB; Semenov LF; Zodelava IG
    Farmakol Toksikol; 1966; 29(4):494-8. PubMed ID: 5987509
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of rat blood on radiation protection of mammalian cells by cysteamine and cystamine in vitro.
    Grant GA; Vos O; Budke L
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 Jul; 28(1):45-51. PubMed ID: 1081090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radioprotective action and possible mechanisms of action of some potential radiation-protective agents].
    Bogatyrev GP; Goncharenko EN; Chirkov IuIu; Kudriashov IuB
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 113(5):50-3. PubMed ID: 4268511
    [No Abstract]   [Full Text] [Related]  

  • 27. [Radioprotective effect of cystamine and mexamine in 2 sequential cell divisions].
    Sidorov VP
    Radiobiologiia; 1981; 21(3):368-73. PubMed ID: 6945628
    [No Abstract]   [Full Text] [Related]  

  • 28. [Formation of fluorescent pigments in lipids].
    Vertushkov VT; Ivanov II
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1973; 115(7):57-60. PubMed ID: 4770228
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of endogenous substances in developing a basis for increased radiation resistance. 5. Mechanism of changes in the level of lipid oxidation products in the radiation protective effect].
    Goncharenko EN; Kudriashov IuB; Zhat'kova GS; Samoĭlikova TI
    Radiobiologiia; 1974; 14(2):210-4. PubMed ID: 4832875
    [No Abstract]   [Full Text] [Related]  

  • 30. ["Thiol" concept of radiosensitivity].
    Graevskiĭ EIa; Tarasenko AG
    Radiobiologiia; 1972; 12(4):483-92. PubMed ID: 4571268
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dose and phase dependency of the radiation protective action of cystamine during prenatal development of the mouse].
    Konermann G
    Strahlentherapie; 1972 Jul; 144(1):96-116. PubMed ID: 5080590
    [No Abstract]   [Full Text] [Related]  

  • 32. [Radioprotectors of the skin].
    Ivanov EV; Ponomareva TV; Merkushev GN; Pil'shchik EM; Livshits RE
    Med Radiol (Mosk); 1978 Nov; 23(11):49-58. PubMed ID: 213671
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the metabolism of Tetrahymena pyriformis GL. V. Protective effect of sulphydryl substances against gamma-irradiation.
    Van de Vijver G
    Enzymologia; 1969 Jun; 36(6):375-85. PubMed ID: 5807260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chemical protection of mice against repeated neutron irradiation].
    Kabukchian TV; Sverdlov AG
    Radiobiologiia; 1975; 15(1):74-8. PubMed ID: 1056604
    [No Abstract]   [Full Text] [Related]  

  • 35. [Change in oxygen tension and oxidation-reduction potential in various organs of mice during the effects of radioprotectors].
    Dobrovol'skiĭ NM
    Radiobiologiia; 1967; 7(2):240-2. PubMed ID: 5621047
    [No Abstract]   [Full Text] [Related]  

  • 36. Study of reactivity of the organism exposed to transverse accelerations and radioprotectants.
    Antipov VV; Vasin MV; Davydov BI; Panchenkova EF; Saxonov PP
    Aerosp Med; 1971 Aug; 42(8):837-9. PubMed ID: 5098574
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peculiarities of the accumulation of neutral red in the organs of the mouse at various intervals after the administration of radiation-protective agents].
    Zherebchenko PG; Zaĭtseva TG
    Radiobiologiia; 1967; 7(1):105-10. PubMed ID: 4305927
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-mercaptoethylamine content of mouse tissues after combined administration of cystamine and 5-methoxytryptamine].
    Mordukhovich VV
    Radiobiologiia; 1975; 15(1):132-6. PubMed ID: 1056603
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index.
    Ozcan Arican G
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):221-9. PubMed ID: 15838658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Somatic and genetic lesions after fractionated x-irradiation and an attempt at chemical radiation protection].
    Baev IA; Baĭrakova AK; Benova DK
    Radiobiologiia; 1974; 14(5):677-80. PubMed ID: 4431911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.